CARERATING
CARE RATINGS LIMITED
Each stock's 10,000-path forecast, rendered as light.
CARE RATINGS LIMITED (CARERATING) Stock Analysis & Case Study
Is CARERATING a good buy? The data-driven verdict.
CARE RATINGS LIMITED (CARERATING) trades at ₹1,749,on the numbers it worth a closer look, a Downstox Snapshot Score of 58/100.
On the numbers, CARE RATINGS LIMITED (CARERATING) worth a closer look, a Downstox Snapshot Score of 58/100, weighing premium at 29.6× earnings, ROE of 19.7%, a 52% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
CARERATING fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How CARERATING ranks against the 2,373 companies in our screener
- CARERATING's market cap of 5,264 Cr ranks in the 66th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- CARERATING's book value of ₹310 ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- CARERATING's 3-year profit (PAT) growth of 27.0% ranks in the 66th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- CARERATING's 3-year revenue growth of 19.0% ranks in the 72nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- CARERATING's debt-to-equity ratio of 0.03x is lower than 90% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
We do not hold a promoter holding figure for CARERATING, as of 9 Aug 2026, so it is not ranked here.
Is CARERATING overvalued? CARERATING P/E vs peers
CARERATING trades at 29.6× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
CARERATING share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of CARERATING history (4%/yr drift, 38%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| CARERATING 2027 | ₹1,098 | ₹1,779 | ₹2,884 | +2% |
| CARERATING 2028 | ₹917 | ₹1,809 | ₹3,571 | +3% |
| CARERATING 2029 | ₹789 | ₹1,840 | ₹4,292 | +5% |
| CARERATING 2030 | ₹707 | ₹1,872 | ₹4,956 | +7% |
| CARERATING 2031 | ₹637 | ₹1,904 | ₹5,694 | +9% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability CARERATING goes up, or doubles?
The bull case for CARERATING
- CARERATING's return on equity of 19.7% ranks in the 83rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- CARERATING's return on capital employed of 26.3% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹4,292.
The bear case & risks
- CARERATING's P/E of 29.6x is lower than 47% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹789.
CARERATING volatility & expected range, how bumpy is the ride?
Over the last 9.8 years CARERATING compounded at 4%/year with annualized volatility of 38%. That volatility implies a 1-year 80% range of ₹1,098-₹2,884, the honest backbone behind any single price target.
CARERATING price forecast, the full 60-month probability fan
CARERATING price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds CARERATING hits common targets within the simulated horizon?
Full multi-horizon detail on the CARERATING price target & forecast page.
CARERATING Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. CARERATING scores 6/8, mixed financial health.
CARERATING MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy CARERATING with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.00% | 2.9× |
| Zerodha | 30.99% | 3.2× |
| Groww | 31.14% | 3.2× |
| DhanCHEAPEST | 30.99% | 3.2× |
| Kotak Neo | 34.97% | 2.9× |
| Paytm Money | 31.27% | 3.2× |
| Pocketful | 31.38% | 3.2× |
| Anand Rathi | 30.99% | 3.2× |
| Bajaj Broking | 35.00% | 2.9× |
| Share India | 31.10% | 3.2× |
Compare every broker on the CARERATING MTF page.
About CARE RATINGS LIMITED: sector, index & market-cap context
CARE RATINGS LIMITED (CARERATING) is a small-cap NSE-listed company, with a market capitalisation of ₹5,264 Cr. See more stocks on our screener.
How the CARERATING Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of CARE RATINGS LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
CARERATING analysis, FAQs
Is CARE RATINGS LIMITED (CARERATING) a good buy?
On the numbers, CARE RATINGS LIMITED (CARERATING) worth a closer look, a Downstox Snapshot Score of 58/100, weighing premium at 29.6× earnings, ROE of 19.7%, a 52% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is CARERATING overvalued or undervalued?
CARERATING trades at 29.6× earnings, premium versus the ~22× long-run Nifty average.
What is the CARERATING share price target for 2031?
CARERATING's probability-weighted 2031 median target is ₹1,904, with an 80% range of ₹637-₹5,694 (10,000-path Monte-Carlo).
What is the probability CARERATING doubles in 5 years?
The modelled probability of CARERATING reaching ₹3,498 (2×) within 5 years is 24%.
What is the bull case for CARERATING?
CARERATING's return on equity of 19.7% ranks in the 83rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. CARERATING's return on capital employed of 26.3% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in CARERATING?
CARERATING's P/E of 29.6x is lower than 47% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.